Picard Medical Reports 85% Revenue Growth, Emperor Platform Update

Picard Medical announced the availability of its pre-recorded presentation for the 2026 Annual Meeting of Stockholders. The presentation highlights strong first-quarter financial performance, including an 85% year-over-year revenue increase and an improved gross margin of 28%. The company also provided updates on manufacturing optimization and significant progress on its next-generation Emperor platform, aiming for a fully implantable total artificial heart. Stockholders will vote on director elections, capital structure amendments, and auditor ratification at the July 17 meeting.